Anagenex is a series a startup based in United States. 1 investor tracked.
Based in the United States, Anagenex is a startup founded in 2019. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Anagenex is a biotechnology company that has developed a data-driven platform for small molecule drug discovery, leveraging machine learning and proprietary DNA-encoded libraries (DELs).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.